These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 32943608)

  • 1. Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer.
    Charan M; Das S; Mishra S; Chatterjee N; Varikuti S; Kaul K; Misri S; Ahirwar DK; Satoskar AR; Ganju RK
    Cell Death Dis; 2020 Sep; 11(9):774. PubMed ID: 32943608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MIF antagonist (CPSI-1306) protects against UVB-induced squamous cell carcinoma.
    Nagarajan P; Tober KL; Riggenbach JA; Kusewitt DF; Lehman AM; Sielecki T; Pruitt J; Satoskar AR; Oberyszyn TM
    Mol Cancer Res; 2014 Sep; 12(9):1292-302. PubMed ID: 24850900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy inhibition in breast cancer cells induces ROS-mediated MIF expression and M1 macrophage polarization.
    Cotzomi-Ortega I; Nieto-Yañez O; Juárez-Avelar I; Rojas-Sanchez G; Montes-Alvarado JB; Reyes-Leyva J; Aguilar-Alonso P; Rodriguez-Sosa M; Maycotte P
    Cell Signal; 2021 Oct; 86():110075. PubMed ID: 34229086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MIF as a potential diagnostic and prognostic biomarker for triple-negative breast cancer that correlates with the polarization of M2 macrophages.
    Chen M; Liu H; Hong B; Xiao Y; Qian Y
    FASEB J; 2024 May; 38(10):e23696. PubMed ID: 38787620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
    Wang C; Zhou X; Li W; Li M; Tu T; Ba X; Wu Y; Huang Z; Fan G; Zhou G; Wu S; Zhao J; Zhang J; Chen J
    Cancer Lett; 2017 Sep; 403():271-279. PubMed ID: 28642171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The small G-protein RalA promotes progression and metastasis of triple-negative breast cancer.
    Thies KA; Cole MW; Schafer RE; Spehar JM; Richardson DS; Steck SA; Das M; Lian AW; Ray A; Shakya R; Knoblaugh SE; Timmers CD; Ostrowski MC; Chakravarti A; Sizemore GM; Sizemore ST
    Breast Cancer Res; 2021 Jun; 23(1):65. PubMed ID: 34118960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer.
    Xiang L; Gilkes DM; Chaturvedi P; Luo W; Hu H; Takano N; Liang H; Semenza GL
    J Mol Med (Berl); 2014 Feb; 92(2):151-64. PubMed ID: 24248265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer.
    Yu TJ; Liu YY; Li XG; Lian B; Lu XX; Jin X; Shao ZM; Hu X; Di GH; Jiang YZ
    Cancer Res; 2021 Nov; 81(21):5491-5505. PubMed ID: 34408002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage migration inhibitory factor is regulated by HIF-1α and cAMP and promotes renal cyst cell proliferation in a macrophage-independent manner.
    Safi W; Kraus A; Grampp S; Schödel J; Buchholz B
    J Mol Med (Berl); 2020 Nov; 98(11):1547-1559. PubMed ID: 32885302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer.
    Kabil N; Bayraktar R; Kahraman N; Mokhlis HA; Calin GA; Lopez-Berestein G; Ozpolat B
    Breast Cancer Res Treat; 2018 Oct; 171(3):593-605. PubMed ID: 29971628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tocilizumab potentiates cisplatin cytotoxicity and targets cancer stem cells in triple-negative breast cancer.
    Alraouji NN; Al-Mohanna FH; Ghebeh H; Arafah M; Almeer R; Al-Tweigeri T; Aboussekhra A
    Mol Carcinog; 2020 Sep; 59(9):1041-1051. PubMed ID: 32537818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel inhibitors of macrophage migration inhibitory factor prevent cytokine-induced beta cell death.
    Vujicic M; Nikolic I; Krajnovic T; Cheng KF; VanPatten S; He M; Stosic-Grujicic S; Stojanovic I; Al-Abed Y; Saksida T
    Eur J Pharmacol; 2014 Oct; 740():683-9. PubMed ID: 24967533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer.
    Ring A; Kaur P; Lang JE
    BMC Cancer; 2020 Nov; 20(1):1076. PubMed ID: 33167919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.
    Xu X; Wang B; Ye C; Yao C; Lin Y; Huang X; Zhang Y; Wang S
    Cancer Lett; 2008 Mar; 261(2):147-57. PubMed ID: 18171602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth.
    Woodcock CC; Huang Y; Woodcock SR; Salvatore SR; Singh B; Golin-Bisello F; Davidson NE; Neumann CA; Freeman BA; Wendell SG
    J Biol Chem; 2018 Jan; 293(4):1120-1137. PubMed ID: 29158255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage migration inhibitory factor siRNA inhibits hepatic metastases of colorectal cancer cells.
    Wu LH; Xia HH; Ma WQ; Zhong HJ; Xu HX; Wang YM; Yang RJ; Wang LJ; Chen Y; Li L; He XX
    Front Biosci (Landmark Ed); 2017 Mar; 22(8):1365-1378. PubMed ID: 28199208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mifepristone Suppresses Basal Triple-Negative Breast Cancer Stem Cells by Down-regulating KLF5 Expression.
    Liu R; Shi P; Nie Z; Liang H; Zhou Z; Chen W; Chen H; Dong C; Yang R; Liu S; Chen C
    Theranostics; 2016; 6(4):533-44. PubMed ID: 26941846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PKCλ/ι signaling promotes triple-negative breast cancer growth and metastasis.
    Paul A; Gunewardena S; Stecklein SR; Saha B; Parelkar N; Danley M; Rajendran G; Home P; Ray S; Jokar I; Vielhauer GA; Jensen RA; Tawfik O; Paul S
    Cell Death Differ; 2014 Sep; 21(9):1469-81. PubMed ID: 24786829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells.
    Baron N; Deuster O; Noelker C; Stüer C; Strik H; Schaller C; Dodel R; Meyer B; Bacher M
    J Neurosci Res; 2011 May; 89(5):711-7. PubMed ID: 21360573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer.
    Lee J; Lim B; Pearson T; Choi K; Fuson JA; Bartholomeusz C; Paradiso LJ; Myers T; Tripathy D; Ueno NT
    Breast Cancer Res Treat; 2019 Jun; 175(2):339-351. PubMed ID: 30826934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.